by Ashley | Mar 18, 2022 | Blog, COVID-19, Stem Cell
Yes, you read that title right. Stem cell therapy for COVID-19 is helping elephants! As you may know, Personalized Stem Cells developed and received FDA approval for a COVID-19 stem cell clinical trial in 2020. We later went on to license that trial to an outside...
by Ashley | Oct 1, 2021 | Blog, Clinical Trial, COVID-19, Stem Cell Therapy
For those who follow our blog, you are probably aware that Personalized Stem Cells (PSC) developed and received FDA approval for a COVID-19 stem cell clinical trial in 2020. We then went on to out-license this clinical trial, along with our allogeneic stem cell...
by Ashley | Jun 11, 2021 | Blog, Clinical Trial, COVID-19
Lately, it seems, we are sharing updates regarding the COVID-19 cell therapy product and clinical trial every other week. The developments seem to be coming at a breakneck speed, as is warranted when faced with a crisis like the COVID-19 pandemic. Our latest news...
by Ashley | Jun 1, 2021 | Clinical Trial, COVID-19, Press Release, Stem Cell
Personalized Stem Cells, Inc (PSC), an adipose-derived stem cell company, announces the Brazilian Health Regulatory Agency (Anvisa) authorized a Phase 2 COVID-19 stem cell clinical trial. This approval comes shortly after the completion of a Phase 1b trial conducted...
by Ashley | May 14, 2021 | Blog, COVID-19, Stem Cell
In our most recent blog, we shared an update regarding the COVID-19 stem cell clinical trial that Personalized Stem Cells developed and secured FDA approval for. The trial, which we licensed to Sorrento Therapeutics, is studying the effects of allogeneic (donor...
